CareinLineDx provides a digital platform that captures customizable e‑PRO surveys and risk assessments, then securely integrates this patient‑generated data into health‑system IT and EHR workflows. The solution enables clinicians to identify at‑risk patients early, personalize treatment plans, and monitor disease progression while offering patients a community portal for support and information.
Funding
Funding not disclosed
Founders
Product
Problem
Patients with rare and chronic diseases often experience fragmented care, with limited integration of patient‑reported outcomes and risk assessments into clinical workflows, leading to delayed interventions and reduced treatment adherence.
Solution
CareinLineDx offers a digital platform that captures custom e‑PRO surveys and personalized risk assessments, then securely integrates this data into existing health‑system IT environments. The solution enables clinicians to identify at‑risk patients early, tailor care plans, and monitor disease progression without disrupting current workflows. Patients gain access to accurate disease information and a community space for peer support, fostering engagement and adherence. By providing configurable service modules, the platform supports a range of rare and chronic conditions, allowing providers to deliver personalized, data‑driven care.
Target Audience
Primary customers are health systems, specialty clinics, and rare‑disease centers seeking to incorporate patient‑reported outcomes into their care pathways, as well as providers managing chronic disease populations.
Features
- Customizable e‑PRO surveys and risk‑assessment tools that incorporate medical history, comorbidities, and patient‑reported data
- Secure, seamless integration with electronic health records and other clinical workflow systems
- Real‑time data acquisition and analytics to support early intervention and personalized treatment plans
- Community portal that connects patients and families for information sharing and emotional support
- Configurable service modules that can be tailored to specific rare or chronic disease pathways
- Consent‑driven data sharing ensuring patient privacy while enabling stakeholder collaboration